Fleischmann R, et al. A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate. ACR 2018, abstract 890.
‘Ik heb mijn plek als reumatoloog gevonden in Brussel’
sep 2024